Mechanism of interleukin-6 cytokine family in bone metastasis of lung cancer and prospects for its application
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
DOI: 10.1016/j.bbcan.2025.189398 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Jinbai Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China; Medical Imaging Department of Health…. Hauptthemen laut MEDLINE: Lung Neoplasms, Bone Neoplasms, Interleukin-6. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 192 Literaturangaben.
Abstract (Originalsprache)
Bone metastasis is a significant clinical problem for lung cancer patients. Current studies have reported a strong relationship between the progression of bone metastases from lung cancer and inflammatory cytokines, which can modulate the tumor microenvironment (TME) and promote the migration of tumor cells. Interleukin-6 (IL-6) family cytokines are critical components of the immune microenvironment secreted by several cell types in vivo. They can regulate immune homeostasis, inflammatory response, etc., and activate multiple signal pathways involved in tumor progression. Some of these factors (e.g., IL-6 and IL-11) increase the serum expression levels of patients with bone metastases from lung cancer; the level of expression correlates with a poor prognosis in patients with lung cancer. However, the role of this family of novel cytokines in lung cancer bone metastasis remains unclear. Besides, limited studies exist on the related regulatory mechanisms, and there is a lack of direct evidence for their relationship with bone metastasis. Thus, this review discusses the current roles and potential mechanisms of all IL-6 family members in lung cancer bone metastasis, as well as the potential of blocking the IL-6 family, its receptors, and signaling pathways for treating lung cancer bone metastasis. This is geared towards providing prospective treatment targets for bone metastases from lung cancer and possible future research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China; Medical Imaging Department of Health Science Center of Yangtze University, Jingzhou 434023, Hubei, China.
- Department of Rehabilitation Radiology, Beijing Rehabilitation Hospital, Capital Medical University, Beijing 100144, China. Electronic address: medimawei@bjmu.edu.cn.
- Department of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, China. Electronic address: caijun0540@163.com.
Zitieren
APA
Huang, J., Zhang, Q., Yang, Y., Wang, W., & Cai, J. (2025). Mechanism of interleukin-6 cytokine family in bone metastasis of lung cancer and prospects for its application. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189398
Vancouver
Huang J, Zhang Q, Yang Y, Wang W, Cai J. Mechanism of interleukin-6 cytokine family in bone metastasis of lung cancer and prospects for its application. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189398
BibTeX
@article{Huang2025,
author = {Huang, Jinbai and Zhang, Qingting and Yang, Yuanshan and Wang, Wei and Cai, Jun},
title = {Mechanism of interleukin-6 cytokine family in bone metastasis of lung cancer and prospects for its application},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
doi = {10.1016/j.bbcan.2025.189398}
}
EUVIMED